Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Diltiazem drug class?Combivent generic equivalent?The expiration date of the key patent for guselkumab?Can turmeric enhance lipitor's efficacy or side effects?Bivalirudin manufacturer?
See the DrugPatentWatch profile for Zavegepant
Zavegepant is a calcitonin gene-related peptide (CGRP) receptor antagonist (a “gepант”) used for the treatment of migraine. It works by blocking the CGRP pathway, which is involved in migraine attacks. [1]
Zavegepant is given as a nasal spray (intranasal). [1]
It is used to treat migraine attacks. [1]
Commonly reported adverse effects for intranasal zavegepant include nasal symptoms (such as irritation or discomfort) and other typical medication side effects seen with migraine therapies, depending on the study and patient group. [1]
Zavegepant is one of the CGRP-pathway antagonists. Other “gepants” exist in different formulations (some are oral rather than nasal), which affects convenience and dosing schedules. Zavegepant’s defining difference is its intranasal route. [1]
Approval status and availability can vary by country and over time. Check your country’s drug regulator or a local pharmacy listing for current status. [1]
Other Questions About Zavegepant :